TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,777,861 | -45.6% | 441,267 | -20.3% | 0.02% | -52.8% |
| Q1 2023 | $12,453,005 | +196.1% | 553,713 | +176.8% | 0.04% | +176.9% |
| Q4 2022 | $4,206,231 | +56.4% | 200,011 | +83.2% | 0.01% | +44.4% |
| Q3 2022 | $2,690,000 | -44.6% | 109,166 | -45.5% | 0.01% | -43.8% |
| Q2 2022 | $4,854,000 | -13.0% | 200,333 | -7.5% | 0.02% | 0.0% |
| Q1 2022 | $5,581,000 | +84.6% | 216,587 | +122.4% | 0.02% | +166.7% |
| Q4 2021 | $3,023,000 | +260.7% | 97,400 | +190.3% | 0.01% | +200.0% |
| Q1 2021 | $838,000 | -22.4% | 33,550 | -15.4% | 0.00% | -33.3% |
| Q4 2020 | $1,080,000 | – | 39,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |